Daily Cosmetic Research Analysis
Analyzed 29 papers and selected 3 impactful papers.
Summary
A Bayesian network meta-analysis found chlorhexidine, particularly around 0.2%, most consistently reduces postoperative infections when used for vaginal antisepsis before cesarean delivery. A prospective cohort showed diastasis recti repair markedly improves gastrointestinal symptoms in postpartum women. A systematic review quantified chronic pain and intercostal nerve injury after breast surgery and highlighted underutilization of microsurgical pain interventions.
Research Themes
- Perioperative infection prevention in obstetrics
- Functional outcomes of aesthetic surgery
- Neuropathic complications following breast surgery
Selected Articles
1. Chlorhexidine is the preferred agent for vaginal antisepsis prior to cesarean delivery: a systematic review and network meta-analysis.
Across 50 trials (n=14,515), vaginal antisepsis before cesarean delivery reduced postoperative infectious morbidity, with chlorhexidine consistently ranking as most effective. Concentration-stratified analyses identified 0.2% chlorhexidine as the top option for wound infection reduction, and results were robust across subgroups and sensitivity analyses.
Impact: Provides comparative effectiveness and ranking by concentration for a widely used perioperative intervention with immediate practice implications. Reverses prior rankings favoring povidone-iodine by leveraging a larger, integrity-screened evidence base.
Clinical Implications: Adopt chlorhexidine for pre-cesarean vaginal antisepsis, preferentially near 0.2% when available; standardize protocols and documentation of concentration. Incorporate into infection prevention bundles alongside antibiotics.
Key Findings
- Vaginal antisepsis reduced endometritis, wound infection, wound complications, and postpartum fever versus no preparation.
- Chlorhexidine was most consistently effective; 0.2% chlorhexidine achieved the highest SUCRA for wound infection (0.995).
- Compared to chlorhexidine, no preparation had higher odds of endometritis (OR 3.65), wound infection (OR 2.34), wound complications (OR 2.28), and fever (OR 3.60).
- Findings were consistent across subgroup and sensitivity analyses, with integrity screening of trials.
Methodological Strengths
- Comprehensive multi-database search with Bayesian network meta-analysis and SUCRA ranking
- Risk-of-bias 2.0 assessment, research integrity screening, and prespecified subgroup/sensitivity analyses
Limitations
- Heterogeneity in antiseptic concentrations and formulations across trials
- Some agents (e.g., clindamycin, cetrimide) supported by few small trials; reliance on indirect comparisons for ranking
Future Directions: Head-to-head RCTs comparing chlorhexidine concentrations; standardization of outcome definitions and follow-up; assessment of safety and tolerance across concentrations.
OBJECTIVE: To compare the effectiveness of vaginal antiseptic preparations administered before cesarean delivery in reducing postoperative infectious morbidity and to assess whether antiseptic type and concentration influence outcomes. DATA SOURCES: PubMed/MEDLINE, Embase, Web of Science, Scopus, the Cochrane Database of Systematic Reviews, the Cochrane Central Register of Controlled Trials, and gray literature sources were searched from January 1, 1990 to January 24, 2025. STUDY ELIGIBILITY CRITERIA: Randomized and quasi-randomized controlled trials of pregnant women undergoing cesarean delivery who received systemic antibiotic prophylaxis and were randomized to vaginal antiseptic preparation vs no vaginal preparation. Eligible studies reported at least one relevant outcome: endometritis, wound infection, wound complications, or postoperative fever. METHODS: Two reviewers independently screened, extracted data, and assessed risk of bias (Cochrane Risk of Bias 2.0) and research integrity using the Trustworthiness in RAndomized Controlled Trials checklist. Primary analyses pooled studies by antiseptic agent, with secondary analyses considering both agent and concentration. Both pairwise random-effects meta-analyses (direct comparisons) and network meta-analyses (indirect and mixed comparisons) were conducted within a Bayesian framework. Odds ratios were reported with 95% credible intervals and 95% prediction intervals. Network meta-analyses additionally estimated comparative effects, generated treatment rankings via the Surface Under the Cumulative Ranking Curve, and assessed global and local inconsistency. Prespecified subgroup analyses examined labor status, membrane rupture, and geographic setting; sensitivity analyses excluded nonliquid preparations and studies deemed untrustworthy. RESULTS: Fifty trials (14,515 participants) evaluated povidone-iodine, chlorhexidine (0.05% to 5%), cetrimide, metronidazole, clindamycin, saline, water, and no vaginal preparation. Compared with patients who received chlorhexidine, those who did not receive vaginal preparation had significantly higher odds of endometritis (odds ratio, 3.65; 95% credible interval, 2.36-5.90), wound infection (odds ratio, 2.34; 95% credible interval, 1.66-3.36), wound complications (odds ratio, 2.28; 95% credible interval, 1.65-3.32), and postpartum fever (odds ratio, 3.60; 95% credible interval, 2.27-5.86) for unspecified concentration. In concentration-stratified analyses, chlorhexidine 0.2% achieved the highest Surface Under the Cumulative Ranking Curve for wound infection (0.995), and chlorhexidine of unspecified concentration ranked highest for fever (0.918). Clindamycin and cetrimide occasionally ranked highly but were supported by few, small trials. Subgroup and sensitivity analyses yielded consistent findings. CONCLUSION: Vaginal antiseptic preparation before cesarean delivery reduces postoperative infectious morbidity. In contrast to earlier network meta-analyses, which identified povidone-iodine 1% as the top-ranked agent, our expanded analysis of 50 trials found chlorhexidine, particularly at low-range to mid-range concentrations, to be the most consistently effective across multiple outcomes, supported by the largest evidence base. Both antiseptic type and concentration influence effectiveness.
2. Improvement of Gastrointestinal Symptoms After Diastasis Recti Repair: A Prospective Study.
In a prospective cohort of 80 postpartum women with diastasis recti, surgical repair led to GI symptom improvement in 97.5% and complete resolution in 68.8%, with marked reductions in bloating, constipation, and abdominal pain. All patients meeting Rome IV criteria for IBS preoperatively no longer met criteria at follow-up.
Impact: Links an aesthetic/musculoskeletal procedure to functional GI benefit, potentially expanding indications and counseling for DRA repair. Quantifies symptom resolution, including IBS remission, with medium-term follow-up.
Clinical Implications: Consider GI symptom assessment in DRA patients and discuss potential functional benefits of repair beyond cosmesis. Multidisciplinary pathways (plastic surgery, pelvic floor, GI) may optimize patient selection and outcomes.
Key Findings
- 97.5% (78/80) reported GI symptom improvement; 68.8% (55/80) had complete resolution after DRA repair.
- Frequent bloating decreased from 95% to 10%, constipation from 50% to 15%, and abdominal pain from 50% to 5%.
- All 15 patients (19%) who met Rome IV IBS criteria preoperatively no longer met criteria at follow-up.
- No patients reported worsening GI symptoms postoperatively.
Methodological Strengths
- Prospective cohort with standardized symptom measures and minimum 6-month follow-up (mean 14 months)
- Clear primary outcome focusing on patient-reported GI symptom change
Limitations
- Single-arm design without a nonoperative comparator; potential selection bias
- Reliance on patient-reported outcomes without objective GI functional testing
Future Directions: Randomized or matched comparative studies versus conservative management; incorporation of objective GI metrics and quality-of-life endpoints; long-term durability beyond 1–2 years.
BACKGROUND: Diastasis recti abdominis (DRA) is a common postpartum condition associated with musculoskeletal impairments. While a link to gastrointestinal (GI) dysfunction is suspected, it remains poorly studied. We hypothesized that surgical correction of DRA would improve associated GI symptoms by restoring abdominal wall integrity and function. METHODS: We conducted a prospective cohort study of 80 postpartum women undergoing surgical repair for DRA. GI symptoms-including bloating, abdominal pain, constipation, and diarrhea-were evaluated before surgery and at a minimum of 6 months post-op (mean follow-up 14 months) using a 5-point Likert scale. The primary outcome was patient-reported change in GI symptoms. RESULTS: At baseline, all patients reported GI disturbances, with bloating (95%) and constipation (50%) being most prevalent; 19% met Rome IV criteria for Irritable Bowel Syndrome (IBS). Following surgical repair, 78 of 80 patients (97.5%) reported improvement in their GI symptoms, with 55 (68.8%) experiencing complete resolution. No patients reported worsening symptoms. The prevalence of frequent bloating dropped from 95 to 10%, constipation from 50 to 15%, and abdominal pain from 50% to 5%. All 15 patients who met IBS criteria preoperatively no longer did at follow-up. CONCLUSIONS: Surgical correction of diastasis recti leads to a significant and near-universal improvement in gastrointestinal symptoms for postpartum women. These findings suggest that DRA is a contributing factor to functional GI disorders in this population and that its repair confers important functional benefits beyond cosmetic and musculoskeletal improvements. LEVEL OF EVIDENCE II: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
3. Nerve injuries following reconstructive and cosmetic breast surgery: A systematic review and meta-analysis.
Among 9,083 patients across 39 studies, chronic pain occurred in 12.6% and nerve injuries in 1.8% after breast surgery, predominantly involving intercostal nerves. Only 9.2% of those with nerve injuries underwent surgical interventions (e.g., neurectomy, neuroma excision), suggesting underutilization of microsurgical options.
Impact: Quantifies the burden of neuropathic complications after common cosmetic and reconstructive breast procedures and highlights opportunities for surgical pain management.
Clinical Implications: Counsel patients on risks of chronic pain and intercostal nerve injury after breast surgery; implement early identification pathways and consider referral to peripheral nerve specialists when conservative measures fail.
Key Findings
- Across 9,083 patients, chronic pain was reported in 12.6% and nerve injuries in 1.8% after breast surgery.
- Intercostal nerves accounted for 98.5% of nerve injuries; brachial plexus involvement was rare (1.5%).
- Only 23 patients (9.2% of those with nerve injuries) underwent surgery (neurectomy 47.8%, neuroma excision 43.5%, implant removal 34.8%).
- Procedures analyzed included augmentation (69.3%), mastectomy with/without reconstruction (25.9%), and reduction (4.9%).
Methodological Strengths
- Systematic multi-database search over two decades with explicit inclusion criteria and pooled analysis
- Large aggregated sample enabling precise estimates of complication frequencies
Limitations
- Predominantly observational evidence with heterogeneity in definitions and follow-up
- Potential publication bias and underreporting of neuropathic outcomes
Future Directions: Prospective cohort registries with standardized neuropathic outcome measures; trials of targeted microsurgical interventions for post-breast surgery neuropathic pain.
BACKGROUND: Breast surgery carries the risk of intercostal nerve injuries, with symptoms ranging from sensory disturbances to chronic pain. This study characterizes post-operative intercostal nerve injuries following breast surgery and available microsurgical management options. METHODS: A systematic review was conducted using PubMed, Embase, Web of Science, and Scopus for the years 2003-2024. The primary inclusion criteria was a patient experiencing any neuropathic symptoms (defined as pain or sensory changes) following mastectomy, breast reconstruction, or aesthetic breast surgery. RESULTS: Of 514 unique studies, 39 (n = 9083 patients) were included. The procedures included breast augmentation (n = 6291, 69.3 %), mastectomy without reconstruction (n = 1701, 18.7 %), mastectomy with reconstruction (n = 654, 7.2 %), and breast reduction (n = 434, 4.9 %). After these procedures, 1144 (12.6 %) patients experienced chronic pain and 135 (1.8 %) had nerve injuries, consisting of intercostal nerves (n = 133, 98.5 %) or brachial plexus nerves (n = 2, 1.5 %). Of patients with nerve injuries, 23 (9.2 %) underwent surgical interventions, which included neurectomy (n = 11, 47.8 %), neuroma excision (n = 10, 43.5 %), implant removal (n = 8, 34.8 %), and dorsal rhizotomy (n = 1, 4.3 %). CONCLUSION: This study demonstrates a substantial risk of chronic pain and peripheral nerve injuries following breast surgery. The low utilization of surgical options (4.6 %) may indicate limited patient unawareness of the pain relief which microsurgical intervention offers when conservative approaches fail in reduction or resolution of symptoms.